{"id":2833,"date":"2021-11-30T10:10:22","date_gmt":"2021-11-30T09:10:22","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2833"},"modified":"2025-05-27T08:21:58","modified_gmt":"2025-05-27T06:21:58","slug":"share-issues-and-corporate-transactions","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/investors\/share-issues-and-corporate-transactions\/","title":{"rendered":"Aktieemissioner och f\u00f6retagstransaktioner"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;88f366a5-bf49-48d9-a338-ab22706b73e7&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;2_3,1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][dipi_breadcrumbs _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;800px&#8221; global_colors_info=&#8221;{}&#8221; global_module=&#8221;5132&#8243; theme_builder_area=&#8221;post_content&#8221;][\/dipi_breadcrumbs][et_pb_divider color=&#8221;#EEEEEE&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;1px&#8221; height=&#8221;20px&#8221; custom_margin=&#8221;||3px|||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;8738c908-7375-4c6c-99a7-9f91f8a3c099&#8243; header_font_size=&#8221;56px&#8221; custom_margin=&#8221;||17px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Share issues and Corporate transactions<\/h6>\n<h1>Share issues and Corporate transactions.<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;50px||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; custom_padding_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;e9afc0e7-c9bf-4a12-be49-63ddba231101&#8243; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; module_id=&#8221;share-issues&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;84px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 style=\"padding-left: 20px;\">Share issues<\/h3>\n<p>[\/et_pb_text][et_pb_accordion toggle_icon=&#8221;&#x33;||divi||400&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_accordion_item title=&#8221;R\u00f6r ej&#8221; open=&#8221;on&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;Display:none;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;New Share Issue 2022&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<h5>Documents are in Swedish.<\/h5>\n<p><a href=\"https:\/\/storage.mfn.se\/de39e7f1-6578-4e4c-920c-7be8865c2402\/arocells-styrelse-foreslar-en-fullt-garanterad-foretradesemission-om-cirka-86-msek.pdf\">Press release Decision on new share issue<\/a><\/p>\n<p><a href=\"https:\/\/storage.mfn.se\/818fecc3-68e8-4867-883e-934bbade4b37\/kallelse-till-extra-bolagsstamma-i-arocell-ab-publ.pdf\">Press release Notice of extraordinary general meeting of AroCell AB<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/01\/AroCell-Prospekt-foretradesemission-2022-01-27.pdf\">Prospectus<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/03\/AroCell-Arsredovisning-2020.pdf\">AroCell \u2013 Annual Report 2020<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2020\/04\/Arsredovisning-2019.pdf\">AroCell \u2013 Annual Report 2019<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/11\/AroCell-Delarsrapport-Q3-2021.pdf\">AroCell \u2013 Q3 2021<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/01\/IDL-Biotech-AR-2020.pdf\">IDL Biotech \u2013 Annual Report 2020<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/01\/IDL-Biotech-AR-2019.pdf\">IDL Biotech \u2013 Annual Report 2019<\/a><\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;New Share Issue 2021&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<h5>Documents are in Swedish.<\/h5>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/06\/Prospekt_-AroCell-AB_FINAL_last.pdf\">Prospectus<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/06\/5565966107_Registreringsbevis_2021-06-08.pdf\">Registration<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/AroCell-Delarsrapport-Q1-2021.pdf\">Interim report 1 January \u2013 31 March 2021<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/03\/AroCell-Arsredovisning-2020.pdf\">Annual Report 2020<\/a><\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;New Share Issue 2019&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<h5><\/h5>\n<h5>Documents are in Swedish.<\/h5>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/11\/Prospekt-191115.pdf\">Prospectus 2019<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/10\/Bilaga-1-%E2%80%93-Styrelsens-redog%C3%B6relse-191022.pdf\">The board\u2019s statement of significant events<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/10\/Bilaga-2-%E2%80%93-Revisorns-yttrande.pdf\">Auditor\u2019s opinion on the board\u2019s statement of significant events<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/10\/Bilaga-3a-%E2%80%93-Beslut-om-f%C3%B6retr%C3%A4desemission-191022.pdf\">The Board of Directors\u2019 decision on rights issue<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/10\/Bilaga-3b-%E2%80%93-Styrelsens-beslut-riktad-emission-191022-.pdf\">The Board of Directors\u2019 decision on a directed issue<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/10\/arocell-announces-directed-share-issue-and-fully-guaranteed-rights-issue-of-sek-54-4m-to-finance-fda-approval-of-arocell-tk-210-elisa.pdf\">Press release Decision on new share issue<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/10\/notice-of-annual-general-meeting-of-arocell-ab-publ.pdf\">Press release notice of additional General Meeting<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/11\/5565966107_Registreringsbevis_2019-11-11.pdf\">Registration Certificate<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/11\/Bolagsordning-h%C3%A4mtad-190909.pdf\">Articles of association<\/a><\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;New Share Issue 2018&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/01\/AroCell_prospekt_2018.03.20-FINAL-1.pdf\">Prospekt<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/01\/Tillaggsprospekt_AroCell-180416-SLUTLIG-LAST-1.pdf\">Till\u00e4ggsprospekt l<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/01\/Tillaggsprospekt-nr-2_AroCell-1.pdf\">Till\u00e4ggsprospekt ll<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/01\/2018-05-22-Sista-dag-for-handel-med-BTA-1.pdf\">2018-05-22 Sista dag f\u00f6r handel med BTA<\/a><\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;Listing At First North 2016 &#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/01\/Bolagsbeskrivning_AroCell_27-juni-20161.pdf\">Listing At First North 2016 (Pdf)<\/a><\/p>\n<p>[\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;New Share Issue 2015&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2019\/01\/Prospekt_AroCell-slutlig1.pdf\">Prospekt<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; module_id=&#8221;corporate-transactions&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3 style=\"padding-left: 20px;\">Corporate transactions<\/h3>\n<h5 style=\"padding-left: 20px;\">Mergers &amp; acquisitions<\/h5>\n<p>[\/et_pb_text][et_pb_accordion toggle_icon=&#8221;&#x33;||divi||400&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;68px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_accordion_item open=&#8221;on&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_css_main_element=&#8221;Display:none;&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_accordion_item][et_pb_accordion_item title=&#8221;Takeover offer of IDL Biotech AB&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221; open=&#8221;off&#8221;]<\/p>\n<h5>Documents are in Swedish.<\/h5>\n<p><a href=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/arocell-ab-publ-lamnar-ett-offentligt-uppkopserbjudan-10-05-2021.pdf\">10 maj 2021 \u2013 AroCell AB (publ) l\u00e4mnar ett offentligt uppk\u00f6pserbjudande till aktie\u00e4garna i IDL Biotech AB (publ)<\/a><\/p>\n<p><a href=\"https:\/\/idldiagnostics.com\/sv\/mfn_news\/arocell-ab-publ-offentliggor-erbjudandehandling-avseende-erbjudandet-till-aktieagarna-i-idl-biotech-ab\/\">8 juni 2021 \u2013 AroCell AB (publ) offentligg\u00f6r erbjudandehandling avseende erbjudandet till aktie\u00e4garna i IDL Biotech AB<\/a><\/p>\n<p><a href=\"https:\/\/storage.mfn.se\/d2566e2b-69b0-4633-b87d-02372076e8c0\/arocell-ab-publ-forklarar-erbjudandet-till-aktieagarna-i-idl-biotech-ab-ovillkorat-och-fullfoljer-erbjudandet.pdf\">1 juli 2021 \u2013 AroCell AB (publ) f\u00f6rklarar erbjudandet till <\/a><a href=\"https:\/\/storage.mfn.se\/d2566e2b-69b0-4633-b87d-02372076e8c0\/arocell-ab-publ-forklarar-erbjudandet-till-aktieagarna-i-idl-biotech-ab-ovillkorat-och-fullfoljer-erbjudandet.pdf\">aktie\u00e4garna i IDL Biotech AB ovillkorat och fullf\u00f6ljer erbjudandet\u00a0<\/a><\/p>\n<p><a href=\"https:\/\/storage.mfn.se\/7971a9c0-0e04-4204-b972-b962576040cb\/arocell-ab-publ-offentliggor-slutligt-utfall-i-erbjudandet-till-aktieagarna-i-idl-biotech-ab.pdf\">1 augusti 2021 \u2013 AroCell AB (publ) offentligg\u00f6r slutligt utfall i erbjudandet till aktie\u00e4garna i IDL Biotech AB<\/a><\/p>\n<p>[\/et_pb_accordion_item][\/et_pb_accordion][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;3464&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;47&#8243; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][et_pb_sidebar area=&#8221;et_pb_widget_area_6&#8243; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74&#8243; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;||||false|false&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2177&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_text_color=&#8221;#21242A&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>About us<\/h6>\n<h3>We provide knowledge to decision.<\/h3>\n<p>AroCell is a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/about-arocell\/&#8221; button_text=&#8221;Read more about us&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg&#8221; title_text=&#8221;MG_7941-600&#8243; src_tablet=&#8221;&#8221; src_phone=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg&#8221; src_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2428&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Bacteriology<\/h6>\n<h3>An effective typhoid test<\/h3>\n<p>Typhoid fever is water and food-borne infectious disease caused by the bacterium, <em>Salmonella<\/em> enterica. IDL Biotechs product TUBEX\u00ae TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/products\/bacteriology\/&#8221; button_text=&#8221;Read more about bacteriology&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;5e8c1032-9074-49bb-92a6-99c20ecc3d02&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-water.jpeg&#8221; title_text=&#8221;Water is Life for African Children, Little Gorgeous Black Girl Drinking from Tap&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2365&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Oncology<\/h6>\n<h3>Diagnostics for oncology<\/h3>\n<p>Cancer is one of the leading causes of death worldwide, despite advancing knowledge. <span>To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.<\/span><\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/products\/oncology\/&#8221; button_text=&#8221;Read more about oncology&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;5e8c1032-9074-49bb-92a6-99c20ecc3d02&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-sunset.jpeg&#8221; title_text=&#8221;Happy smiling running beagle dog portrait with tongue out and owner female jogging by the mounting meadow grass path. Walking in nature with pets, happy healthy active people lifestyle concept image.&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class=\"et_pb_module dipi_breadcrumbs dipi_breadcrumbs_0\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<div class=\"et_pb_module_inner\">\n\t\t\t\t\t<div class=\"dipi-breadcrumbs dipi-bc-left\">\n                <ul >\n                    \n                                                        <li  class=\"dipi-breadcrumb-item dipi-breadcrumb-home\">\n\n                                                    <a  href=\"https:\/\/idldiagnostics.com\/se\">\n                                <span  content=\"Home\">\n                                                                        IDL Diagnostics                                <\/span>\n                            <\/a>\n\n                                                <meta itemprop=\"position\" content=\"1\"\/>                    <\/li>\n\n                    <li class=\"dipi-breadcrumb-separator\">\n                    <span class=\"et-pb-icon dipi-separator-icon\">&#x35;<\/span>\n                <\/li>                            \n                <\/ul>\n            <\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>Share issues and Corporate transactions Share issues and Corporate transactions.Share issuesDocuments are in Swedish. Press release Decision on new share issue Press release Notice of extraordinary general meeting of AroCell AB Prospectus AroCell \u2013 Annual Report 2020 AroCell \u2013 Annual Report 2019 AroCell \u2013 Q3 2021 IDL Biotech \u2013 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2856,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"dipi_cpt_category":[],"class_list":["post-2833","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Share issues and Corporate transactions - IDL Diagnostics<\/title>\n<meta name=\"description\" content=\"Share issues and Corporate transactions.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/investors\/share-issues-and-corporate-transactions\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Share issues and Corporate transactions - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Share issues and Corporate transactions.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/investors\/share-issues-and-corporate-transactions\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-27T06:21:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/share-issues-and-corporate-transactions\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/share-issues-and-corporate-transactions\\\/\",\"name\":\"Share issues and Corporate transactions - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"datePublished\":\"2021-11-30T09:10:22+00:00\",\"dateModified\":\"2025-05-27T06:21:58+00:00\",\"description\":\"Share issues and Corporate transactions.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/share-issues-and-corporate-transactions\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/share-issues-and-corporate-transactions\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/share-issues-and-corporate-transactions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investors\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/investors\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Share issues and Corporate transactions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Share issues and Corporate transactions - IDL Diagnostics","description":"Aktieemissioner och f\u00f6retagstransaktioner.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/investors\/share-issues-and-corporate-transactions\/","og_locale":"sv_SE","og_type":"article","og_title":"Share issues and Corporate transactions - IDL Diagnostics","og_description":"Share issues and Corporate transactions.","og_url":"https:\/\/idldiagnostics.com\/se\/investors\/share-issues-and-corporate-transactions\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_modified_time":"2025-05-27T06:21:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/investors\/share-issues-and-corporate-transactions\/","url":"https:\/\/idldiagnostics.com\/investors\/share-issues-and-corporate-transactions\/","name":"Share issues and Corporate transactions - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"datePublished":"2021-11-30T09:10:22+00:00","dateModified":"2025-05-27T06:21:58+00:00","description":"Aktieemissioner och f\u00f6retagstransaktioner.","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/investors\/share-issues-and-corporate-transactions\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/investors\/share-issues-and-corporate-transactions\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/investors\/share-issues-and-corporate-transactions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"Investors","item":"https:\/\/idldiagnostics.com\/investors\/"},{"@type":"ListItem","position":3,"name":"Share issues and Corporate transactions"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2833","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=2833"}],"version-history":[{"count":6,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2833\/revisions"}],"predecessor-version":[{"id":5149,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2833\/revisions\/5149"}],"up":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/pages\/2856"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=2833"}],"wp:term":[{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=2833"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}